New to PETMETRIX PULSE? This 'start-here' guide covers the PULSE schema, how to separate 'Observed' facts from 'Assessed' interpretation, and a 15‑minute routine to turn each edition into owner‑assigned actions, segmented by operator group.
Chewy added debt as it spent on acquisitions, new sites and share buybacks. Petco’s product sales fell as services and other revenue grew. This edition also covers Fi’s recall of two dog supplement lots, screwworm prevention uses and updated kidney care guidance for cats. The focus is orders, clinic earnings and the costs of stock, staff and growth.
US FDA proposed an animal-drug compounding policy for registered facilities, while Vetsource reported deeper declines in visits, product revenue and preventive dispensing. This PULSE edition also covers canine diabetes guidance, staff-reported care-decline thresholds, a bedinvetmab X-ray pattern in selected safety reports and Vet Intel’s acquisition of Antelligence.
PetMeds reported a 19.9% net sales fall and lower cash. Simparica TRIO received FDA emergency authorization to treat screwworm in dogs, while language models missed cases surgeons classified for surgery. This edition also covers IDEXX’s planned Cancer Dx additions, Battery Ventures’ Vetspire investment and copyright suits alleging unlicensed image use by veterinary practices.
Zoetis’ US companion animal revenue fell; Elanco’s US Pet Health revenue grew. Tractor Supply added more than 200 pet products; Medi-Span launched veterinary drug checks; Trupanion’s subscription pets grew as total enrollment fell. This edition covers MWI’s settlement over drug-order allegations and a federal complaint seeking to halt Darwin’s pet food production.
Two US practice data samples showed more revenue while visit, client, invoice or patient counts fell. US pet insurers wrote more direct premiums in 2025; Merck and Hill’s global sales rose in the second quarter. American Regent recalled 2 Adequan Canine lots after it found glass fibers.
Tractor Supply plans to close about 75 Petsense stores, and Central Garden & Pet agreed to buy about 80% of TRIXIE. Mexico’s screwworm certificate rule starts August 3, and Vermont approved entry controls; Royal Canin expanded Amazon access. This edition also covers customer stock cuts, a delayed launch shipment and 3 recalled cyclophosphamide lots.
CVS pages conflicted on pet-prescription availability, and Texas added three screwworm zones and revised Zone 14.A. This edition also covers FDA animal-drug manufacturing incentives, Four Corners’ purchase of 102 Mission-operated properties, and Virbac companion animal growth alongside lower total North American revenue.
Revenue rose while patient counts and preventive purchases fell. Zoetis agreed to buy VitalRADS, and Bond Vet and Small Door completed their merger. This edition also covers Royal Canin’s fresh therapeutic dog diets, the PetMeds–Rural King online pharmacy, and an FDA proposal for shared registration across linked drug-making sites.
Revenue rose while clients, patients and key purchases fell this week. This edition also covers OpenVet’s public beta and clinic AI rules, FDA and Pedigree product-record updates, General Mills pet sales with lower organic sales, and MiDOG’s parasite-only test for unresolved parasite cases. The early watch item tracks whether Waltham FelQoL moves from research use into feline visit forms, client reports or nutrition materials.
This weeks payment, fresh food, refill, product safety, supplement, and travel questions are adding clinic workflow checks. Signals cover Thrive, Hill’s, PetMed Express, bedinvetmab safety monitoring, Wuffes at PetSmart, and New World screwworm travel rules. The Doubtless launch is an early watch item, will it link insurance, wellness plans, and clinic tools?
Revenue stayed positive this week, but data showed weaker patients, invoices, clients, and purchases. Heart + Paw care plans make clinics check service completion, technician time, and renewals. MSD allergy switching data show pressure on refill follow-up and cost explanations. AVMA’s FIP and poison-call updates add prescription-handoff, compounding, exposure question, and medicine-storage checks. Early watch items include Prime Day price checks and New World screwworm intake steps.
Revenue is still rising, but visits, patients, and invoices are moving lower. The gap puts more weight on the checks behind each case, including where refills go, what products are stocked, how New World screwworm calls are handled, who signs artificial intelligence notes, and whether insurance status is captured at intake.
